All News

Findings from the ProtecT trial, the European Randomized study of Screening for Prostate Cancer, and PIVOT were among the other noteworthy studies in prostate cancer presented at the AUA annual meeting.

Among the AUA annual meeting take-home messages in basic science is that the immune co-stimulatory molecule B7-H4 is highly expressed in the luminal subtype of bladder urothelial carcinoma and is associated with poor survival.

The safety and viability of outpatient percutaneous nephrolithotomy and predictors of success after shock wave lithotripsy were among the research highlights in endourology/stones at the AUA annual meeting.

Other key studies in trauma/reconstruction from AUA 2017 evaluated transcorporal artificial urinary sphincter placement using local tunica albuginea flaps and a model for predicting the risk of urethral stricture recurrence after anterior urethroplasty.

Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.

As some assets appreciate in value and others lose value, your portfolio’s allocation changes. Rebalancing is the remedy for asset drift and an important part of maintaining a healthy investment portfolio.

Henry Rosevear, MD, discusses his experience with the On-Demand Course Pass for this year’s AUA annual meeting, including the two On-Demand courses he found most informative.

Findings from a recent study also suggest that obesity may be a factor to consider for men with prostate cancer deciding between active surveillance and definitive treatment.

Urology Times reached out to three urologists (selected randomly) and asked them each the following: Are anticholinergic drugs overused in treating OAB?

Men who experience a prostate biopsy-related complication are more likely to seek active treatment for clinically localized prostate cancer than those who do not experience a complication, according to findings from a review of the Surveillance, Epidemiology, and End Results Medicare linked database.

A new study suggests that surgical care for renal trauma cases is evolving in two different directions: Endovascular procedures have become more common for blunt trauma, supplanting nephrectomy and laceration repair.

Results of a retrospective case-cohort study show no significant differences in surgical outcomes among men who did and did not have preoperative magnetic resonance imaging of the prostate prior to radical prostatectomy for prostate cancer.

"The health care field does not show any signs of slowing in pace or growth, and as many people view health care as a service, it is important to strive for an environment that is high in quality, care, support, and acceptance," writes SUNA's Amy Hull, MSN, WHNP-BC.

Continuing its participation in the Choosing Wisely campaign, the AUA has added five new recommendations about tests and treatments that physicians and patients should question.

“We strongly believe that PSA-based prostate cancer screening should be made available, especially to men 70 years and older to decrease the morbidity and mortality of prostate cancer,” write Navin Shah, MD, and Vladimir Ioffe, MD.

A 3-month old baby born with atypical genitalia has an XY karyotype. The baby undergoes diagnostic laparoscopy. The baby is doing clinically well without medication.

“Abiraterone should change the treatment paradigm for patients with newly diagnosed metastatic prostate cancer and largely displaces chemotherapy from the current paradigm,” said Sumanta Kumar Pal, MD.

Administering bone supportive therapy within 1 month prior to starting radium Ra 223 dichloride (Xofigo) may increase the likelihood of achieving pain palliation with the radionuclide therapy and reduce the chance of pain flare, according to the findings of a retrospective study.

Findings of a meta-analysis show that phosphodiesterase type 5 inhibitor use is associated with a statistically significant increased risk of melanoma, but they do not support a causal relationship.

Researchers have observed an association between a lifetime of inactivity and higher risks for bladder and renal cancers.

There are no notable differences in overall survival, disease-specific survival, and progression-free survival between radical cystectomy and bladder-preserving combined modality treatment for muscle-invasive bladder cancer, according to a recent meta-analysis.

A new look at the burnout rate among practicing urologists shows that the problem may not be as widespread as previously reported. Nevertheless, nearly 40% of urologists are burned out, a number researchers say is still much too high.

In this interview, Raj S. Pruthi, MD, discusses the factors behind burnout and steps that can be taken to address and prevent it.

Urologist Henry Rosevear, MD, reviews his personal highlights from AUA 2017, along with a few bumps in the road.

The FDA has approved pembrolizumab (Keytruda) for treating any solid tumors that exhibit DNA mismatch repair deficiency.

While drug importation may sound like a good option to reduce drug costs, the potential can of worms it could create isn’t worth it, the AACU’s Ally Lopshire writes.

Among the guideline’s recommendations is that active surveillance should serve as the preferred method of care for low-risk localized prostate cancer.

Diagnostic magnetic resonance imaging strategies for the diagnosis of prostate cancer should be considered prior to biopsy of suspicious lesions, according to a recent study.